Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens

International Journal of Antimicrobial Agents

Volumn 33, Issue 5, 2009, Pages 449-452

  Alou, L ^a   Gimenez M J ^a   Manso, F ^b   Sevillano, D ^a   Torrico, M ^a   Gonzalez N ^a   Granizo, J J ^c   Bascones, A ^d   Prieto, J ^a   Maestre, J R ^e   Aguilar, L ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c Grana Datos SL   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e UNIVERSIDAD ALFONSO X EL SABIO   (Spain)

Author keywords

Amoxicillin; Periodontopathogens; Tinidazole

Indexed keywords

AMOXICILLIN; BETA LACTAMASE; TINIDAZOLE;

AGAR DILUTION; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FUSOBACTERIUM NUCLEATUM; GINGIVITIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIODONTAL DISEASE; PREVOTELLA; PREVOTELLA BUCCAE; PREVOTELLA DENTICOLA; PREVOTELLA INTERMEDIA; PREVOTELLA MELANINOGENICA; PREVOTELLA ORALIS; PRIORITY JOURNAL; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; VEILLONELLA;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; FUSOBACTERIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PERIODONTAL DISEASES; PREVOTELLA; STREPTOCOCCUS; TINIDAZOLE; VEILLONELLA;

EID: 62949243902     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.10.012     Document Type: Article

References (28)

1. Aguilar L., and Giménez M.J. La teoría unitaria en la etiopatogenia de la infección odontogénica. In: Bascones A., Noguerol B., and Prieto J. (Eds). Infecciones odontogénicas en la comunidad y antibioterapia: dos factores a sincronizar (2006), Adalia farma/GETECCU, Madrid, Spain 25-36
2. Prescription des antibiotiques en odontologie et stomatologie. Recommandations et argumentaire. Agence Française de Sécurité Sanitaire des Produits de la Santé; 2001. http://www.afssaps.sante.fr. [accessed 29 October 2008].
3. Chow A.W. Infections of the oral cavity, neck, and head. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. (2005), Elsevier Churchill Livingstone, Philadelphia, PA 787-802
4. Darveau R.P., Tanner A., and Page R.C. The microbial challenge in periodontitis. Periodontol 2000 14 (1997) 12-32
5. Tanner A., and Stillman N. Oral and dental infections with anaerobic bacteria: clinical features, predominant pathogens, and treatment. Clin Infect Dis 16 Suppl 4 (1993) S304-S309
6. Tatakis D.N., and Kumar P.S. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 49 (2005) 491-516
7. Preshaw PM, Seymour RA, Heasman PA. Current concepts in periodontal pathogenesis. Dent Update 2004; 31:570-2, 574-8.
8. Kumar P.S., Leys E.J., Bryk J.M., Martinez F.J., Moeschberger M.L., and Griffen A.L. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 44 (2006) 3665-3673
9. Sobottka I., Cachovan G., Stürenburg E., Ahlers M.O., Laufs R., Platzer U., et al. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 46 (2002) 4019-4021
10. Dahlén G. Microbiology and treatment of dental abscesses and periodontal-endodontic lesions. Periodontol 2000 28 (2002) 206-239
11. Rylev M., and Kilian M. Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 35 8 Suppl. (2008) 346-361
12. Sanz M., van Winkelhoff A.J., Herrera D., Dellemijn-Kippuw N., Simon R., and Winkel E. Differences in the composition of the subgingival microbiota of two periodontitis populations of different geographical origin. A comparison between Spain and The Netherlands. Eur J Oral Sci 108 (2000) 383-392
13. Yano-Higuchi K., Takamatsu N., He T., Umeda M., and Ishikawa I. Prevalence of Bacteroides forsythus. Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in subgingival microflora of Japanese patients with adult and rapidly progressive periodontitis. J Clin Periodontol 27 (2000) 597-602
14. Papapanou P.N., Teanpaisan R., Obiechina N.S., Pithpornchaiyakul W., Pongpaisal S., Pisuithanakan S., et al. Periodontal microbiota and clinical periodontal status in a rural sample in southern Thailand. Eur J Oral Sci 110 (2002) 345-352
15. Haffajee A.D., Bogren A., Hasturk H., Feres M., Lopez N.J., and Socransky S.S. Subgingival microbiota of chronic periodontitis subjects from different geographic locations. J Clin Periodontol 31 (2004) 996-1002
16. Maestre J.R., Bascones A., Sánchez P., Matesanz P., Aguilar L., Giménez M.J., et al. Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain. Rev Esp Quimioter 20 (2007) 61-67
17. Castelli M., Malagoli M., Ruberto A.I., Baggio A., Casolari C., Cermelli C., et al. In-vitro studies of two 5-nitroimidazole derivatives. J Antimicrob Chemother 40 (1997) 19-25
18. Wood B.A., Faulkner J.K., and Monro A.M. The pharmacokinetics, metabolism and tissue distribution of tinidazole. J Antimicrob Chemother 10 Suppl A (1982) 43-57
19. Manso F., Gamboa M., Giménez M., Bascones A., Gómez-Lus M., and Aguilar L. Why not revisiting tinidazole as potential treatment of odontogenic infections?. Rev Esp Quimioter 21 (2008) 198-202
20. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 7th ed. Approved standard. Document M11-A7. Wayne, PA: CLSI; 2007.
21. Tenenbaum H., Jehl F., Gallion C., and Dahan M. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol 24 (1997) 804-807
22. Liew V., Mack G., Tseng P., Cvejic M., Hayden M., and Buchanan N. Single-dose concentrations of tinidazole in gingival crevicular fluid, serum, and gingival tissue in adults with periodontitis. J Dent Res 70 (1991) 910-912
23. Spangler S.K., Jacobs M.R., and Appelbaum P.C. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. J Antimicrob Chemother 39 Suppl B (1997) 23-27
24. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne PA: CLSI; 2008.
25. Loesche W.J., and Grossman N.S. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 14 (2001) 727-752
26. Loesche W.J. The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit Rev Oral Biol Med 10 (1999) 245-275
27. Katsandri A., Avlamis A., Pantazatou A., Petrikkos G.L., Legakis N.J., Papaparaskevas J., et al. In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains. Diagn Microbiol Infect Dis 55 (2006) 231-236
28. Behra-Miellet J., Calvet L., Mory F., Muller C., Chomarat M., Bézian M.C., et al. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey. Anaerobe 9 (2003) 105-111